Stefanie Enzenmüller

562 total citations
15 papers, 392 citations indexed

About

Stefanie Enzenmüller is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Stefanie Enzenmüller has authored 15 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Infectious Diseases. Recurrent topics in Stefanie Enzenmüller's work include Cell death mechanisms and regulation (6 papers), Cancer therapeutics and mechanisms (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). Stefanie Enzenmüller is often cited by papers focused on Cell death mechanisms and regulation (6 papers), Cancer therapeutics and mechanisms (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). Stefanie Enzenmüller collaborates with scholars based in Germany, United States and Italy. Stefanie Enzenmüller's co-authors include Klaus‐Michael Debatin, Simone Fulda, Patrick Gonzalez, Holger Barth, Georg Karpel‐Massler, Mike‐Andrew Westhoff, Lisa Nonnenmacher, Sascha Pust, Farhan Basit and Silvia Cristofanon and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Stefanie Enzenmüller

15 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefanie Enzenmüller Germany 10 250 104 83 65 52 15 392
Chelsea M. Ruller United States 11 295 1.2× 104 1.0× 96 1.2× 111 1.7× 108 2.1× 14 542
Liesong Chen China 9 214 0.9× 133 1.3× 96 1.2× 47 0.7× 60 1.2× 22 379
Christopher D. Riffkin Australia 8 222 0.9× 73 0.7× 50 0.6× 54 0.8× 89 1.7× 8 333
Jianli Sang China 14 361 1.4× 89 0.9× 72 0.9× 31 0.5× 83 1.6× 37 554
Xuehuo Zeng United States 9 320 1.3× 399 3.8× 52 0.6× 50 0.8× 51 1.0× 10 610
Qilan Li China 12 221 0.9× 121 1.2× 85 1.0× 29 0.4× 45 0.9× 24 398
Colin A. Bill United States 10 261 1.0× 119 1.1× 70 0.8× 25 0.4× 91 1.8× 22 496
Taeyun A. Lee South Korea 11 189 0.8× 157 1.5× 45 0.5× 174 2.7× 23 0.4× 13 389
Xiaodong Zhu China 8 183 0.7× 84 0.8× 27 0.3× 200 3.1× 137 2.6× 19 461
Xiarong Shi United States 12 325 1.3× 56 0.5× 49 0.6× 52 0.8× 100 1.9× 15 576

Countries citing papers authored by Stefanie Enzenmüller

Since Specialization
Citations

This map shows the geographic impact of Stefanie Enzenmüller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Enzenmüller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Enzenmüller more than expected).

Fields of papers citing papers by Stefanie Enzenmüller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Enzenmüller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Enzenmüller. The network helps show where Stefanie Enzenmüller may publish in the future.

Co-authorship network of co-authors of Stefanie Enzenmüller

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Enzenmüller. A scholar is included among the top collaborators of Stefanie Enzenmüller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Enzenmüller. Stefanie Enzenmüller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Enzenmüller, Stefanie, Felix Seyfried, Daniel Tews, et al.. (2024). Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylation. Cell Death and Disease. 15(7). 475–475. 3 indexed citations
2.
Bender, Johanna, et al.. (2024). The dual BCL-2 and BCL-XL inhibitor AZD4320 acts on-target and synergizes with MCL-1 inhibition in B-cell precursor ALL. Blood Advances. 8(23). 6035–6042. 1 indexed citations
4.
Trentin, Luca, Manon Queudeville, Elena Boldrin, et al.. (2018). Leukemia reconstitution in vivo is driven by cells in early cell cycle and low metabolic state. Haematologica. 103(6). 1008–1017. 4 indexed citations
5.
Karpel‐Massler, Georg, Shaoxia Zhou, Neil O. Carragher, et al.. (2018). Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approach. Scientific Reports. 8(1). 5527–5527. 17 indexed citations
6.
Wang, Fan, Salih Demir, Felix Seyfried, et al.. (2018). Tight regulation of FOXO1 is essential for maintenance of B-cell precursor acute lymphoblastic leukemia. Blood. 131(26). 2929–2942. 24 indexed citations
8.
Schneider, Marc, Elisabeth Hauser, Stefanie Enzenmüller, et al.. (2015). Cytotoxic and Apoptotic Effects of Recombinant Subtilase Cytotoxin Variants of Shiga Toxin-Producing Escherichia coli. Infection and Immunity. 83(6). 2338–2349. 17 indexed citations
9.
Schneider, Matthias, Lisa Nonnenmacher, Markus D. Siegelin, et al.. (2015). A paired comparison between glioblastoma “stem cells” and differentiated cells. International Journal of Cancer. 138(7). 1709–1718. 37 indexed citations
10.
Westhoff, Mike‐Andrew, Georg Karpel‐Massler, Stefanie Enzenmüller, et al.. (2014). A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy. PubMed. 2(1). 32–32. 44 indexed citations
11.
Westhoff, Mike‐Andrew, Lisa Nonnenmacher, Stefanie Enzenmüller, et al.. (2013). Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma. PLoS ONE. 8(12). e83128–e83128. 42 indexed citations
12.
Enzenmüller, Stefanie, Patrick Gonzalez, Klaus‐Michael Debatin, & Simone Fulda. (2012). Chloroquine overcomes resistance of lung carcinoma cells to the dual PI3K/mTOR inhibitor PI103 by lysosome-mediated apoptosis. Anti-Cancer Drugs. 24(1). 14–19. 34 indexed citations
13.
Gonzalez, Patrick, Aurélie Tchoghandjian, Stefanie Enzenmüller, et al.. (2012). Impairment of lysosomal integrity by B10, a glycosylated derivative of betulinic acid, leads to lysosomal cell death and converts autophagy into a detrimental process. Cell Death and Differentiation. 19(8). 1337–1346. 91 indexed citations
14.
Enzenmüller, Stefanie, Patrick Gonzalez, Georg Karpel‐Massler, Klaus‐Michael Debatin, & Simone Fulda. (2012). GDC-0941 enhances the lysosomal compartment via TFEB and primes glioblastoma cells to lysosomal membrane permeabilization and cell death. Cancer Letters. 329(1). 27–36. 27 indexed citations
15.
Pust, Sascha, et al.. (2008). ADP-Ribosylation of Actin by theClostridium botulinumC2 Toxin in Mammalian Cells Results in Delayed Caspase-Dependent Apoptotic Cell Death. Infection and Immunity. 76(10). 4600–4608. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026